Journal of Cancer Science and Research
Open Access

Oncological Perspectives and Drug Resistance of Cellular Membranes in Cancer

Teskim Qozani^{* *}Correspondence: Teskim Qozani, Department of Medical Microbiology, Bahir Dar University, Bahir Dar, Ethiopia, Email:

Author info »

About the Study

The cellular membrane, a very complex structure which controls the passage of molecules, maintains the stability of cells, and coordinates many necessary functions crucial for a cell's survival. In recent years, research has revealed the key role of the cellular membrane in the development and progression of cancer [1]. The interaction between membrane components and cancer has provided major discoveries into the disease's mechanisms, diagnosis, and potential therapeutic interventions. The cellular membrane, commonly known as the plasma membrane, captures the cell and regulates the exchange of substances in and out of it. Composition of a phospholipid bilayer surrounded with proteins, the membrane acts as a selectively permeable barrier, allowing the movement of specific molecules while blocking others. This barrier function is fundamental for maintaining cellular homeostasis.

Cancer and alterations in the cellular membrane

In cancer, the cellular membrane undergoes important alterations that contribute to the disease progression. These changes are complicated and include various aspects, from modifications in membrane composition to altered signaling and interaction with the surrounding environment [2]. Several membrane-related changes contribute to the development of cancer:

Membrane transport proteins: Dysregulation of ion channels and pumps in the cellular membrane can affect the balance of ions within the cell, resulting cell proliferation and apoptosis. Abnormalities in ion channels have been associated with various cancers [3].

Cell Adhesion Molecules (CAMs): Changes in CAMs can lead to reduced cell adhesion, allowing cancer cells to separate from the primary tumor and invade surrounding tissues [4]. E-cadherin is a key CAM frequently involved in cancer metastasis.

Glycosylation patterns: Changes in glycosylation patterns on the cell surface affect cell adhesion, migration, and immune response. Abnormal glycosylation is a common feature in cancer, influencing tumor invasion and metastasis.

Altered lipid composition: One of the notable changes observed in cancer cells is the modification in lipid composition within the cellular membrane [5]. Studies have shown alterations in lipid metabolism, leading to changes in the types and proportions of lipids present in the membrane. These modifications can impact membrane fluidity, structural integrity, and the behavior of membrane-bound proteins, influencing various cellular processes.

Pathways of abnormal regulation in Signaling

The cellular membrane plays a key role in signal transduction. Variations in signaling pathways due to mutations or abnormal protein expression affect the membrane's ability to transmit, receive, and interpret signals correctly [6]. This can lead to uncontrolled cell growth, prevention of cell death, and improved cell migration.

Impact on cell adhesion and migration: Cell adhesion and migration are important for the invasion and metastasis of cancer cells. Alterations in the cellular membrane affect these processes by modifying the expression and function of adhesion molecules and receptors [7]. This allows cancer cells to disconnect from the primary site, invade surrounding tissues, and migrate to distant locations within the body.

Role in drug resistance: The cellular membrane also influences the response of cancer cells to treatments. Efflux pumps located on the membrane can expel drugs, reducing their efficacy. Changes in membrane composition and the presence of certain proteins can contribute to drug resistance, making cancer cells more challenging to eliminate [8].

Diagnostic and therapeutic consequences

Understanding the role of the cellular membrane in cancer has important effects for both diagnosis and treatment strategies.

Biomarkers for diagnosis: With the changes in membrane composition and signaling, specific components of the cellular membrane can serve as potential biomarkers for cancer detection and diagnosis. Techniques targeting membrane proteins or lipid profiles show ability in developing non-invasive diagnostic tools for various cancer types.

Targeted therapies: The advantage of the limitations in the altered membrane has emerged as a promising avenue for cancer treatment. Targeted therapies focusing on membrane-associated proteins or pathways have shown effectiveness in specific cancer types [9]. For instance, drugs targeting specific membrane receptors or lipid metabolism pathways have shown success in certain cancers.

Future Directions and Challenges

While the understanding of the role of the cellular membrane in cancer has advanced significantly, there are challenges for further exploration.

Complexity of interactions: The interactions between the cellular membrane and cancer are highly complex and interconnected. Understanding the multifaceted nature of these interactions poses a significant challenge. Researchers are frequently exploring these interactions to identify key players and resolve the complex web of relationships.

Therapeutic resistance: Even with advancements in targeted therapies, the development of resistance remains an important challenge [10]. Cancer cells can adapt and develop mechanisms to avoid targeted treatments, demonstrating the need for a deeper understanding of cellular membrane-related resistance mechanisms.

Conclusion

The cellular membrane's role in cancer is a complex and key aspect of the disease. Its alterations impact various cellular functions, driving the development and progression of cancer. Understanding these changes has provided insights into diagnostic markers and potential therapeutic targets, offering hope for more effective and personalized cancer treatments. Continued research into the complexities of the cellular membrane in cancer will likely lead to further breakthroughs, potentially transforming the landscape of cancer care. The development of drug resistance in cellular membranes leads to an interesting challenge in cancer treatment. Cellular membranes, fundamental to drug transport and signaling, exhibit adaptive mechanisms that inhibit efficiency of therapeutic agents. This resistance, often mediated by membrane proteins and altered lipid compositions, limits drug delivery and promotes survival of cancer cells. Overcoming membrane-related drug resistance requires innovative approaches, such as targeted drug delivery systems and combination therapies. Understanding the complex interaction between cellular membranes and drug resistance is chief for advancing cancer treatment strategies and improving patient outcomes.

References

1. Lyman GH. Weight-based chemotherapy dosing in obese patients with cancer: Back to the future. J Oncol Pract. 2012;8(4):62-64.

   [Crossref] [PubMed] [Google Scholar]

2. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219-234.

   [Crossref] [PubMed] [Google Scholar]

3. Pérez-Tomás R. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr Med Chem. 2006;13(16):1859-1876.

   [Crossref] [PubMed] [Google Scholar]

4. Larsen AK, Skladanowski A. Cellular resistance to topoisomerase-targeted drugs: From drug uptake to cell death. Biochim Biophys Acta. 1998;1400(1-3):257-274. 

   [Crossref] [PubMed] [Google Scholar]

5. Gottesman MM. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002;53:615â??627.

   [Crossref] [PubMed] [Google Scholar]

6. Shapira A, Livney YD, Broxterman HJ, Assaraf YG. Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance. Drug Resist Updat. 201;14(3):150-163.

   [Crossref] [PubMed] [Google Scholar]

7. Qiao L, Wong BC. Targeting apoptosis as an approach for gastrointestinal cancer therapy. Drug Resist Updat. 2009;12(3):55-64.

   [Crossref] [PubMed] [Google Scholar]

8. Gao Z, Zhang L, Sun Y. Nanotechnology applied to overcome tumor drug resistance. J Control Release. 2012;162(1):45-55.

   [Crossref] [PubMed] [Google Scholar]

9. Gao J, Feng SS, Guo Y. Nanomedicine against multidrug resistance in cancer treatment. Nanomedicine (Lond). 2012;7(4):465-468.

   [Crossref] [PubMed] [Google Scholar]

10. Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 2006;580(12):2903-2909.

    [Crossref] [PubMed] [Google Scholar]